CARDIX Therapeutics LLC (CARDIX LLC) was founded in 2016 in the U.S. and is located in San Diego, CA. CARDIX LLC is developing an innovative patent drug to improve cardiac function by increasing heart rate and cardiac output. The new patent drug provides an alternative option to a pacemaker for treating chronic bradycardia and improving cardiac function. With a non-invasive methodology and non-electromagnetic interference, it is promising to be suitable for astronauts/spacemen to protect or ameliorate their cardiac function in Space.
Patent information is available upon request.